Gene-editing a significant leap forward in biomedical research but needs strong legal framework for ethical usage, says GlobalData

Following the recent claims by He Jiankui, a scientist and professor of Biology at the Southern University of Science and Technology in Shenzhen, Guangdong, China, that he has successfully created the world's first gene-edited babies,

David Brown, Medical Device Analyst at GlobalData, a leading data and analytics company, offers his view:

“While this claim remains unverified by a third party, He’s claim has drawn a great deal of international criticism due to the fact that human genome editing has not been proven to be safe, and acceptable ethical guidelines have yet to be fully drafted or agreed upon. Genomic editing in viable human embryos is banned to various degrees in many countries.

“In China, however, there are no clear laws in place to prevent these actions, only guidelines. He’s claims highlight both the immediate need to develop strong international agreements on the ethical usage of human genome editing, and the necessity of strong legal frameworks surrounding what modifications, if any, are permitted. If He’s claims are true, it represents a significant leap forward in the field of biomedical research and is expected to propel the advancement of products and technologies in this space on a global level.”


For more information

To gain access to our latest press releases: GlobalData Media Centre

Analysts available for comment. Please contact the GlobalData Press Office:


EMEA & Americas: +44 (0)207 832 4399
Asia-Pacific: +91 40 6616 6809

To gain access to our latest press releases and expert analysis on developments in your industry, please connect with us on: | LinkedIn | Twitter

About GlobalData

4,000 of the world’s largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make more timely and better business decisions thanks to GlobalData’s unique data, expert analysis and innovative solutions, all in one platform. GlobalData’s mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors.

Back to news